Oragenics Stock Technical Analysis

OGEN Stock  USD 0.66  0  0.53%   
As of the 16th of February 2026, Oragenics holds the Risk Adjusted Performance of (0.11), coefficient of variation of (684.51), and Variance of 22.18. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Oragenics, as well as the relationship between them.

Oragenics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Oragenics, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to OragenicsOragenics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Oragenics Analyst Consensus

Target PriceConsensus# of Analysts
2.0Hold1Odds
Oragenics current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Oragenics analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Oragenics stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Oragenics, talking to its executives and customers, or listening to Oragenics conference calls.
Oragenics Analyst Advice Details
Will Biotechnology sector continue expanding? Could Oragenics diversify its offerings? Factors like these will boost the valuation of Oragenics. Anticipated expansion of Oragenics directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Oragenics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
48.21
Quarterly Revenue Growth
(0.91)
Return On Assets
(0.71)
Return On Equity
(1.69)
Investors evaluate Oragenics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Oragenics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Oragenics' market price to deviate significantly from intrinsic value.
It's important to distinguish between Oragenics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Oragenics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Oragenics' market price signifies the transaction level at which participants voluntarily complete trades.

Oragenics 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Oragenics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Oragenics.
0.00
11/18/2025
No Change 0.00  0.0 
In 3 months and 1 day
02/16/2026
0.00
If you would invest  0.00  in Oragenics on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Oragenics or generate 0.0% return on investment in Oragenics over 90 days. Oragenics is related to or competes with AIM ImmunoTech, Kala Pharmaceuticals, Ensysce Biosciences, Soligenix, Can Fite, Xenetic Biosciences, and CNS Pharmaceuticals. Oragenics, Inc. develops antibiotics for infectious diseases in the United States More

Oragenics Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Oragenics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Oragenics upside and downside potential and time the market with a certain degree of confidence.

Oragenics Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Oragenics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Oragenics' standard deviation. In reality, there are many statistical measures that can use Oragenics historical prices to predict the future Oragenics' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Oragenics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.030.675.54
Details
Intrinsic
Valuation
LowRealHigh
0.050.995.86
Details
1 Analysts
Consensus
LowTargetHigh
1.822.002.22
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.17-0.17-0.17
Details

Oragenics February 16, 2026 Technical Indicators

Oragenics Backtested Returns

Oragenics maintains Sharpe Ratio (i.e., Efficiency) of -0.14, which implies the firm had a -0.14 % return per unit of risk over the last 3 months. Oragenics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Oragenics' Coefficient Of Variation of (684.51), variance of 22.18, and Risk Adjusted Performance of (0.11) to confirm the risk estimate we provide. The company holds a Beta of 1.51, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Oragenics will likely underperform. At this point, Oragenics has a negative expected return of -0.69%. Please make sure to check Oragenics' total risk alpha, as well as the relationship between the skewness and day median price , to decide if Oragenics performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.42  

Average predictability

Oragenics has average predictability. Overlapping area represents the amount of predictability between Oragenics time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Oragenics price movement. The serial correlation of 0.42 indicates that just about 42.0% of current Oragenics price fluctuation can be explain by its past prices.
Correlation Coefficient0.42
Spearman Rank Test0.51
Residual Average0.0
Price Variance0.01
Oragenics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Oragenics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Oragenics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Oragenics Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Oragenics volatility. High ATR values indicate high volatility, and low values indicate low volatility.

About Oragenics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Oragenics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Oragenics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Oragenics price pattern first instead of the macroeconomic environment surrounding Oragenics. By analyzing Oragenics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Oragenics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Oragenics specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2025 2026 (projected)
Dividend Yield6.66E-43.66E-4
Price To Sales Ratio1.6K2.9K

Oragenics February 16, 2026 Technical Indicators

Most technical analysis of Oragenics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Oragenics from various momentum indicators to cycle indicators. When you analyze Oragenics charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Oragenics February 16, 2026 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Oragenics stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether Oragenics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Oragenics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Oragenics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Oragenics Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oragenics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued.
To learn how to invest in Oragenics Stock, please use our How to Invest in Oragenics guide.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Will Biotechnology sector continue expanding? Could Oragenics diversify its offerings? Factors like these will boost the valuation of Oragenics. Anticipated expansion of Oragenics directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Oragenics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
48.21
Quarterly Revenue Growth
(0.91)
Return On Assets
(0.71)
Return On Equity
(1.69)
Investors evaluate Oragenics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Oragenics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Oragenics' market price to deviate significantly from intrinsic value.
It's important to distinguish between Oragenics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Oragenics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Oragenics' market price signifies the transaction level at which participants voluntarily complete trades.